The 2022 American Diabetes Association Meeting

Bloomgarden, Zachary T.

doi:10.1111/1753-0407.13297

Cited by 2 publications

(2 citation statements)

References 95 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the mean age of the recruited patients was higher than that of the current study (71±9-years-old). Additionally, Bloomgarden (18) found that people with diabetes have a 3-fold higher likelihood of being hospitalised than people without the condition.…”

Section: Discussionmentioning

confidence: 99%

High Sensitivity Cardiac Troponin T in Patients with Type 2 Diabetes Mellitus, Relation to Cardiac Metabolic Risk Factors: Hypertension and Truncal Obesity

Asy

Ahmed²,

Attia³

et al. 2023

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: Diabetes mellitus type 2 (T2DM) is a prevalent metabolic disease that predisposes to diabetic cardiomyopathy and cardiovascular diseases (CVD). High sensitivity cardiac troponin T (hs-cTnT) can determine who is most at risk for developing cardiovascular issues and diabetes. Objective: To evaluate the relation between high-sensitive cardiac troponin T and cardiac metabolic risks (hypertension and truncal obesity) in patient with T2DM. Patients and Methods: A prospective cohort study included 50 diabetic patients reached at the emergency units of

show abstract

Section: Discussionmentioning

confidence: 99%

High Sensitivity Cardiac Troponin T in Patients with Type 2 Diabetes Mellitus, Relation to Cardiac Metabolic Risk Factors: Hypertension and Truncal Obesity

Asy

Ahmed²,

Attia³

et al. 2023

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

show abstract

“…To the editors, We read with great interest the synopsis of the 2022 meeting of the American Diabetes Association by the Editor-in-Chief of the Journal of Diabetes, Professor Z. Bloomgarden. 1 In addition to exciting and novel research data, a highlight of the congress was the presentation of the draft of the new American Diabetes Association/European Association for the Study of Diabetes (EASD) consensus on the management of hyperglycemia in type 2 diabetes (T2D). 2 The consensus is expected to be shaped in its final form at the upcoming EASD congress, which will be held in Stockholm, Sweden, in September 2022.…”

mentioning

confidence: 99%